Legal Representation
Attorney
Mary Catherine Merz
USPTO Deadlines
Next Deadline
1064 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-06-07)
Due Date
June 07, 2028
Grace Period Ends
December 07, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
27 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 7, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Jun 7, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| May 31, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Apr 29, 2022 | DP1B | I | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| Apr 28, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Mar 28, 2022 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Mar 28, 2022 | IUCN | S | NOTICE OF ALLOWANCE CANCELLED |
| Mar 8, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Jan 11, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jan 11, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Dec 22, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Dec 3, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Dec 3, 2021 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| Dec 3, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Dec 3, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Dec 3, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Dec 3, 2021 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Dec 2, 2021 | DOCK | D | ASSIGNED TO EXAMINER |
| Jul 22, 2021 | ALIE | A | ASSIGNED TO LIE |
| Jul 22, 2021 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Jul 19, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jul 19, 2021 | ALIE | A | ASSIGNED TO LIE |
| Jul 12, 2021 | ALIE | A | ASSIGNED TO LIE |
| Jul 2, 2021 | ALIE | A | ASSIGNED TO LIE |
| Jul 1, 2021 | ALIE | A | ASSIGNED TO LIE |
| Apr 28, 2021 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Apr 15, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
(Based on 44(e)) (Based on Use in Commerce) Nutraceuticals, namely, supplements for the treatment of HPV, namely, Human Papilloma Virus and associated conditions, specifically, genital warts and cervical dysplasia; (Based on Use in Commerce) Nutritional supplements containing herbs and nutrients that benefit the immune system
First Use Anywhere:
20090500
First Use in Commerce:
20090500
Classification
International Classes
005